Showing results (761-770 of 821) with videos related to

Sort By:
Pageof 83
La Radiologia Medica|February 12, 2024
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspectiveMarco Lorenzo Bonù, Luca Nicosia, Ana Turkaj, et al.
The Journal of Clinical Investigation|October 5, 2016
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressivenessJulie Leca, Sébastien Martinez, Sophie Lac, et al.
Nature Neuroscience|August 10, 2023
Modeling idiopathic autism in forebrain organoids reveals an imbalance of excitatory cortical neuron subtypes during early neurogenesisAlexandre Jourdon, Feinan Wu, Jessica Mariani, et al.
Journal of Geriatric Oncology|May 19, 2022
Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancerAnne-Laure Couderc, Laetitia Ninove, Emilie Nouguerède, et al.
Cell Death & Disease|January 16, 2015
Stromal SLIT2 impacts on pancreatic cancer-associated neural remodelingV Secq, J Leca, C Bressy, et al.
Frontiers in Oncology|November 10, 2022
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patientsMarco Lorenzo Bonù, Salvatore La Mattina, Navdeep Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018Olivier Bylicki, Pascale Tomasini, Gervais Radj, et al.
The Oncologist|May 18, 2024
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanomaEmily Connell, Émilie Gerard, Bénédicte Oules, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2007
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentMeritxell Gironella, Mylène Seux, Min-Jue Xie, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2023
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world studyLionel Falchero, Florian Guisier, Marie Darrason, et al.
Pageof 83